These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 479629)

  • 21. Immunological evaluation of urinary trypsin inhibitors in blood and urine: role of N- & O-linked glycoproteins.
    Pugia MJ; Jortani SA; Basu M; Sommer R; Kuo HH; Murphy S; Williamson D; Vranish J; Boyle PJ; Budzinski D; Valdes R; Basu SC
    Glycoconj J; 2007 Jan; 24(1):5-15. PubMed ID: 17115277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
    Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical atherosclerosis in psoriatic disease: relation to endocan, TNF-α, age of onset, and body fat.
    Elkamshoushi AM; Omar SS; El Abd AM; Hassan SZ; Sultan EA; Abd Elkawy E
    Int J Dermatol; 2019 Apr; 58(4):456-464. PubMed ID: 30471086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers.
    Santella RM; Nunes MG; Blaskovic R; Perera FP; Tang D; Beachman A; Lin JH; DeLeo VA
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):137-40. PubMed ID: 8049634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between urinary albumin excretion and skin involvement in patients with psoriasis.
    Cecchi R; Seghieri G; Gironi A; Tuci F; Giomi A
    Dermatology; 1992; 185(2):93-5. PubMed ID: 1421637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients.
    Tekin NS; Tekin IO; Barut F; Sipahi EY
    Mediators Inflamm; 2007; 2007():78454. PubMed ID: 17497039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study.
    Eedy DJ; Johnston CF; Shaw C; Buchanan KD
    J Invest Dermatol; 1991 Apr; 96(4):434-8. PubMed ID: 2007781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease.
    Eissa A; Cretu D; Soosaipillai A; Thavaneswaran A; Pellett F; Diamandis A; Cevikbas F; Steinhoff M; Diamandis EP; Gladman D; Chandran V
    Clin Chem Lab Med; 2013 Feb; 51(2):317-25. PubMed ID: 23096109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development of a radioimmunoassay for Tamm--Horsfall glycoprotein in serum.
    Dawnay A; McLean C; Cattell WR
    Biochem J; 1980 Mar; 185(3):679-87. PubMed ID: 7387630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased urinary polyamines in patients with psoriasis treated with etretinate.
    Grekin RC; Ellis CN; Goldstein NG; Swanson NA; Anderson TF; Duell EA; Voorhees JJ
    J Invest Dermatol; 1983 Mar; 80(3):181-4. PubMed ID: 6827127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of a novel glycoprotein from the urine of a patient with chronic myelocytic leukemia.
    Rudman D; Chawla RK; Del Rio AE; Hollins B
    J Clin Invest; 1974 Mar; 53(3):868-74. PubMed ID: 4204683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of a novel glycoprotein (EDC1) from the urine of a patient with acute myelocytic leukemia.
    Rudman D; Chawla RK; Hendrickson LJ; Vogler WR; Sophianopoulos AJ
    Cancer Res; 1976 May; 36(5):1837-46. PubMed ID: 57827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic biomarkers for psoriasis and psoriasis arthritis.
    Reindl J; Pesek J; Krüger T; Wendler S; Nemitz S; Muckova P; Büchler R; Opitz S; Krieg N; Norgauer J; Rhode H
    J Proteomics; 2016 May; 140():55-61. PubMed ID: 27063990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of O-glycosylated proteins that are aberrantly excreted in the urine of patients with early stage ovarian cancer.
    Mu AK; Lim BK; Hashim OH; Shuib AS
    Int J Mol Sci; 2013 Apr; 14(4):7923-31. PubMed ID: 23579955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary thymine dimers and 8-oxo-2'-deoxyguanosine in psoriasis.
    Ahmad J; Cooke MS; Hussieni A; Evans MD; Patel K; Burd RM; Bleiker TO; Hutchinson PE; Lunec J
    FEBS Lett; 1999 Nov; 460(3):549-53. PubMed ID: 10556533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased levels of plasma vitronectin in severe psoriatic patients.
    Nogita T; Kawashima M
    Arch Dermatol Res; 1992; 284(5):315-7. PubMed ID: 1280069
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary Orosomucoid A Potential Marker Of Inflammation In Psoriasis.
    Kustán P; Kőszegi T; Miseta A; Péter I; Ajtay Z; Kiss I; Németh B
    Int J Med Sci; 2018; 15(11):1113-1117. PubMed ID: 30123048
    [No Abstract]   [Full Text] [Related]  

  • 38. Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers.
    Cretu D; Gao L; Liang K; Soosaipillai A; Diamandis EP; Chandran V
    Arthritis Care Res (Hoboken); 2018 Mar; 70(3):454-461. PubMed ID: 28586166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
    Abdou AG; Hanout HM
    J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.